Abstract
Background Compared to other components of social cognition, knowledge of social norms has received less attention, even more so in Alzheimer’s disease (AD). While semantic memory deficits have been identified early in the course of AD, no study has delved into the knowledge of social norms at these preliminary stages, although evidence suggests it shares common ground with semantic memory. In addition, it is unclear whether the knowledge of social norms in AD is associated socioemotional deficits, as seen in the behavioral variant of frontotemporal dementia (bvFTD). Finally, how social norms knowledge impairments predict behaviours in real-world settings remains unknown in the context of AD.
Methods This study included 286 participants with mild cognitive impairment (MCI), 157 with AD, 285 with bvFTD along with 384 older healthy controls. All participants were selected from the National Alzheimer’s Coordinating Center. They completed the Social Norms Questionnaire, which assesses the tendency to break or overadhere to social norms. They also completed tests assessing executive, semantic and socioemotional functions, along with tests measuring spontaneous interpersonal behaviours.
Results Between-group comparisons show that individuals with AD and MCI break and overadhere to social norms significantly more than HC, while they perform better than individuals with bvFTD. Knowledge of social norms was mainly associated with semantic knowledge across groups, and predicted insensitivity and disinhibition severity in patients.
Conclusions This study suggests that declines in semantic memory likely play a key role in social norms knowledge decreases and that these decreases predict behavioural tendencies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data from the National Alzheimer's Coordinating Center (NACC) were used. The NACC obtained approvals from the Institutional Review Boards of all participating institutions.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
